These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

954 related items for PubMed ID: 19640573

  • 41. Central venous catheter-associated complications in infants with single ventricle: comparison of umbilical and femoral venous access routes.
    Aiyagari R, Song JY, Donohue JE, Yu S, Gaies MG.
    Pediatr Crit Care Med; 2012 Sep; 13(5):549-53. PubMed ID: 22805159
    [Abstract] [Full Text] [Related]

  • 42. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
    Bassi KK, Giri AK, Pattanayak M, Abraham SW, Pandey KK.
    Indian J Cancer; 2012 Sep; 49(1):114-8. PubMed ID: 22842178
    [Abstract] [Full Text] [Related]

  • 43. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
    Chang YF, Lo AC, Tsai CH, Lee PY, Sun S, Chang TH, Chen CC, Chang YS, Chen JR.
    Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
    [Abstract] [Full Text] [Related]

  • 44. Antibiotic prophylaxis in the placement of totally implanted central venous access ports.
    Scaife CL, Gross ME, Mone MC, Hansen HJ, Litz CL, Nelson ET, Anderson CJ, Wagner G, Gawlick U, Nelson EW.
    Am J Surg; 2010 Dec; 200(6):719-22; disussion 722-3. PubMed ID: 21146010
    [Abstract] [Full Text] [Related]

  • 45. Clinical practices concerning central venous catheters in haematological patients.
    Boersma RS, Schouten HC.
    Eur J Oncol Nurs; 2010 Jul; 14(3):200-4. PubMed ID: 20117964
    [Abstract] [Full Text] [Related]

  • 46. The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.
    Fagnani D, Bertolini A, Catena L, Tomirotti M, Visini M, Alatri A, De Paoli A, Aondio GM, Milani M, Arpaia G, Cimminiello C, POLONORD Group, Franchi R, Porta C, Pugliese P, Borgonovo K, Duro M, Ardizzoia A, Filipazzi V, Isa L, Vergani C, Carpenedo M, Viale P.
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):35-40. PubMed ID: 20523163
    [Abstract] [Full Text] [Related]

  • 47. Placement and management of long-term central venous access catheters and ports.
    Denny DF.
    AJR Am J Roentgenol; 1993 Aug; 161(2):385-93. PubMed ID: 8333382
    [Abstract] [Full Text] [Related]

  • 48. A prospective observational study on 249 subcutaneous central vein access ports in a Swedish county hospital.
    Taxbro K, Berg S, Hammarskjöld F, Hanberger H, Malmvall BE.
    Acta Oncol; 2013 Jun; 52(5):893-901. PubMed ID: 23432403
    [Abstract] [Full Text] [Related]

  • 49. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R, Corrado F, de Braud F, de Lucia F, Scarpa D, Testori A, Orsi F, Bellomi M, Mauri S, Aapro M, Andreoni B.
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [Abstract] [Full Text] [Related]

  • 50. Peripheral venous access ports: outcomes analysis in 109 patients.
    Bodner LJ, Nosher JL, Patel KM, Siegel RL, Biswal R, Gribbin CE, Tokarz R.
    Cardiovasc Intervent Radiol; 2000 Jul; 23(3):187-93. PubMed ID: 10821892
    [Abstract] [Full Text] [Related]

  • 51. Peripherally placed totally implantable venous-access port systems of the forearm: clinical experience in 763 consecutive patients.
    Goltz JP, Scholl A, Ritter CO, Wittenberg G, Hahn D, Kickuth R.
    Cardiovasc Intervent Radiol; 2010 Dec; 33(6):1159-67. PubMed ID: 20414657
    [Abstract] [Full Text] [Related]

  • 52. Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study.
    Mollee P, Jones M, Stackelroth J, van Kuilenburg R, Joubert W, Faoagali J, Looke D, Harper J, Clements A.
    J Hosp Infect; 2011 May; 78(1):26-30. PubMed ID: 21459476
    [Abstract] [Full Text] [Related]

  • 53. [Central venous catheters in children with cancer. Risk of complications. One centre experience].
    Perek D, Kowalewska E, Czajnska A, Polnik D, Drogosiewicz M, Stefanowicz M.
    Med Wieku Rozwoj; 2006 May; 10(3 Pt 1):757-65. PubMed ID: 17317906
    [Abstract] [Full Text] [Related]

  • 54. [Complications related to permanent deep venous catheterization using dual lumen hemodialysis catheter].
    Zhang P, Yuan J, Chen JH, Wu JY, Zhang XH, Jiang H.
    Zhonghua Nei Ke Za Zhi; 2004 Mar; 43(3):198-200. PubMed ID: 15059375
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
    Debourdeau P, Zammit C, Pavic M, Bensaid B, Farge-Bancel D.
    Rev Med Interne; 2007 Jul; 28(7):471-83. PubMed ID: 17561314
    [Abstract] [Full Text] [Related]

  • 60. Principles of subcutaneous port placement.
    Gonda SJ, Li R.
    Tech Vasc Interv Radiol; 2011 Dec; 14(4):198-203. PubMed ID: 22099011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.